FAQ

Humira

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2017
010203020032017

Related topics

Related topics

1 relation

Broader (1)

adalimumab

Related mentions per year

Related mentions per year

1984-2018
19801990200020102020
Humira
adalimumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Toxicity of high-dose intravitreal adalimumab (Humira) in the rabbit.
PURPOSE To evaluate the ocular toxicity of escalating doses of intravitreous adalimumab (Humira®) in the rabbit eye. METHODS… (More)
Is this relevant?
2009
2009
Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF.
PROBLEM The purpose of this study was to investigate whether treatment with TNF-alpha inhibitors and/or intravenous… (More)
  • table I
Is this relevant?
2009
2009
Infliximab therapy for refractory uveitis: 2-year results of a prospective trial.
 
Is this relevant?
2009
2009
Evaluation of potential retinal toxicity of adalimumab (Humira)
The purpose of this study is to evaluate the retinal toxicity of two doses of adalimumab (Humira), a recombinant human IgG1… (More)
  • figure 1
  • figure 2
Is this relevant?
2008
2008
Ocular toxicity of intravitreous adalimumab (Humira) in the rabbit
To evaluate the ocular toxicity of escalating doses of intravitreous adalimumab (Humira) in the rabbit eye. Twelve New Zealand… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
What's fueling the biotech engine—2007
 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Adalimumab in the therapy of uveitis in childhood.
PURPOSE Chronic anterior uveitis in children often takes a serious course. Despite various immunosuppressive drugs some children… (More)
Is this relevant?
2005
2005
Adalimumab (Humira) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade) or etanercept (Enbrel): results from the STURE registry at Karolinska University…
OBJECTIVES To determine whether the tumour necrosis factor-alpha (TNF-alpha) antagonist adalimumab (Humira) can be efficacious… (More)
Is this relevant?
2005
2005
Treatment of orbital myositis with adalimumab (Humira).
Adalimumab is a fully humanized IgG1 monoclonal antibody to tumor necrosis factor-a. We describe 2 patients (17 and 13 years of… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial…
OBJECTIVE This study, known as STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis), evaluated the safety and efficacy of… (More)
Is this relevant?